Diaceutics PLC (FRA:7DC)

Diaceutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	140	128	84	72	102	125
Market Cap Growth	17.48%	51.80%	17.69%	-29.68%	-18.50%	49.55%
Enterprise Value	130	109	65	50	74	92
Last Close Price	1.63	1.45	1.02	0.84	1.16	1.68
PE Ratio	-	-	-	87.95	152.85	426.74
PS Ratio	3.49	3.30	3.09	3.27	6.15	8.84
PB Ratio	3.22	2.66	1.80	1.50	2.11	2.79
P/TBV Ratio	5.49	4.34	2.87	2.32	3.06	3.59
P/FCF Ratio	12008.01	192.50	61.82	12.97	17150.06	967.52
P/OCF Ratio	1154.62	162.93	55.93	12.50	150.44	443.61
EV/Sales Ratio	3.31	2.81	2.39	2.29	4.46	6.50
EV/EBITDA Ratio	74.59	163.86	555.87	21.53	40.96	194.30
EV/EBIT Ratio	-	-	-	77.74	112.96	-
EV/FCF Ratio	11106.05	164.16	47.81	9.10	12425.86	711.89
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.00
Debt / EBITDA Ratio	0.74	1.50	4.73	0.60	1.00	0.28
Debt / FCF Ratio	113.40	1.92	1.02	0.27	312.20	1.02
Asset Turnover	0.77	0.68	0.50	0.42	0.32	0.39
Quick Ratio	3.66	3.66	6.11	8.07	11.24	11.33
Current Ratio	3.96	3.80	6.40	8.24	11.41	11.53
Return on Equity (ROE)	-4.00%	-4.22%	-4.19%	1.74%	1.39%	0.87%
Return on Assets (ROA)	-2.85%	-3.23%	-3.99%	0.77%	0.78%	-0.51%
Return on Capital (ROIC)	-3.27%	-3.70%	-4.40%	0.83%	0.83%	-0.56%
Return on Capital Employed (ROCE)	-5.40%	-6.00%	-7.20%	1.30%	1.30%	-0.70%
Earnings Yield	-1.27%	-1.61%	-2.38%	1.14%	0.65%	0.23%
FCF Yield	0.01%	0.52%	1.62%	7.71%	0.01%	0.10%
Buyback Yield / Dilution	-0.19%	-0.27%	2.16%	-1.35%	-9.14%	-21.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.